A freshwater snail that can regrow a fully formed eye is beginning to attract quiet attention from researchers studying vision loss. The golden apple .

Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter ...

CRISPR Therapeutics’ fourth quarter was relatively disappointing. As a biotech start-up still in its infancy though, these early quarterly numbers don’t mean much. The foreseeable future looks bright ...

A new study reports that cannabidiol (CBD), a non-intoxicating component of marijuana, may exploit a specific ion channel and a mitochondrial pathway to kill cells from a rare type of ovarian tumor.

FuturaGene has announced that its new gene-edited eucalyptus, approved by Brazil's National Biosafety Technical Commission (CTNBio), aims to reduce chemical inputs and energy consumption in industrial ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...

Koo joins from South Korean firm Yulchon, where he was a partner. At ToolGen he will help lead the company’s efforts to monetise its IP portfolio through royalty income. He will work alongside ...

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...

For most of his 20 years, a New Jersey man knew pain as a daily reality. Now, after a one-time CRISPR gene-editing treatment at Children's Hospital of Philadelphia, Austin Louis says he is finally ...

The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...

Producing high levels of valuable medicinal compounds in plants has long been limited by the difficulty of precisely ...

A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance.